31 Mar 2019
Assets253.05
Total Income285.86
EBITDA72.76
Profit After Tax39.42
NET Worth334.86
Reserves and Surplus79.15
Total Borrowing89.84
At a glance
Updated 2026-08-23Supriya Lifescience is a Mainboard IPO with an issue size of ₹700.00 crore, proposed for listing on BSE, NSE. The offer opens on 16th Dec 2021 and closes on 20th Dec 2021. The issue structure includes a fresh issue of ₹200.00 crore and an offer-for-sale component of ₹500.00 crore. The current listing schedule points to 28th Dec 2021.
Issue details
Listing atBSE, NSE
Issue typeBook Build Issue
Issue size₹700.00 Cr
Fresh issue₹200.00 Cr
Offer for sale₹500.00 Cr
Face value₹2
Price band₹265.00–₹274.00
Allotment23rd Dec 2021
Listing28th Dec 2021
Grey market
GMP page ↗Latest GMP₹130.00
GMP / upper price47.45%
Est. listing₹404.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens16th Dec 2021
Closes20th Dec 2021
Allotment23rd Dec 2021
Refund24th Dec 2021
Demat27th Dec 2021
Listing28th Dec 2021
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Use of proceeds
| Object | Amount |
|---|---|
| Funding capital expenditure requirements of the Company; | ₹92.30 Cr |
| Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the Company | ₹60.00 Cr |
| General corporate purposes. | ₹35.95 Cr |
Financials
Full financials ↗31 Mar 2020
Assets336.43
Total Income322.71
EBITDA109.45
Profit After Tax73.40
NET Worth268.94
Reserves and Surplus134.56
Total Borrowing82.21
31 Mar 2021
Assets445.82
Total Income396.22
EBITDA178.15
Profit After Tax123.83
NET Worth149.19
Reserves and Surplus254.31
Total Borrowing70.13
30 Sep 2021
Assets504.10
Total Income230.06
EBITDA98.67
Profit After Tax65.96
NET Worth93.79
Reserves and Surplus320.23
Total Borrowing70.99
Trend chart₹ crore
KPIs
| KPI | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | BRLMs fees and commissions (including underwriting commission) | 16.52 |
| 2 | Commission/processing fee for SCSBs, Sponsor Bank and Bankers to the Offer. Brokerage and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | 5.86 |
| 3 | Fees payable to the Registrar to the Offer | 1.21 |
| 4 | Fees payable to the other advisors to the Offer | 0.53 |
| 5 | Others | |
| 6 | - Listing fees, SEBI filing fees, upload fees, BSE & NSE processing fees, book building software fees and other regulatory expenses | 3.37 |
| 7 | - Printing and stationery | 2.53 |
| 8 | - Advertising and marketing expenses | 5.59 |
| 9 | - Fee payable to legal counsels | 2.95 |
| 10 | - Miscellaneous | 2.56 |
Issue expenses
| Expense | Amount |
|---|---|
| BRLMs fees and commissions (including underwriting commission) | ₹16.52 Cr |
| Commission/processing fee for SCSBs, Sponsor Bank and Bankers to the Offer. Brokerage and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | ₹5.86 Cr |
| Fees payable to the Registrar to the Offer | ₹1.21 Cr |
| Fees payable to the other advisors to the Offer | ₹0.53 Cr |
| Others | — |
| - Listing fees, SEBI filing fees, upload fees, BSE & NSE processing fees, book building software fees and other regulatory expenses | ₹3.37 Cr |
| - Printing and stationery | ₹2.53 Cr |
| - Advertising and marketing expenses | ₹5.59 Cr |
| - Fee payable to legal counsels | ₹2.95 Cr |
| - Miscellaneous | ₹2.56 Cr |
Registrar & lead managers
Registrar
MUFG Intime India Pvt.Ltd.Lead managers
- ICICI Securities Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-23.